Related Experiment Video
Updated: Jun 17, 2026
13:11
Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
Published on: July 12, 2012
Identification and Verification of Key Genes Underlying Methamphetamine Sensitization Using Network-Based Analysis
Ali Mohammadian1, Afsaneh Mokaram Bakhtajerdi2, Zahra Mortezaei3
1Department of Bioinformatics and Applied Biotechnology, Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran.
Cell Journal
|June 16, 2026
Summary
Methamphetamine (METH) alters gene expression in brain reward circuits. This study identified key genes and potential drugs to reverse these addiction-related changes in the nucleus accumbens.
Area of Science:
- Neuroscience
- Genomics
- Pharmacology
Background:
- Methamphetamine (METH) is a psychostimulant causing addiction by altering gene expression in brain reward circuits.
- The nucleus accumbens (NAc) is a critical brain region involved in reward processing and METH addiction.
Purpose of the Study:
- To identify METH-associated transcriptional changes in the NAc.
- To explore potential pharmacological interventions for METH addiction.
Main Methods:
- In silico analysis of microarray data (GSE46717) to identify differentially expressed genes (DEGs).
- Functional enrichment analysis and protein-protein interaction (PPI) network construction to identify hub genes.
- Experimental validation using quantitative polymerase chain reaction (qPCR) in rat NAc tissue.
- Connectivity mapping to identify potential therapeutic drugs.
Main Results:
- Identified 280 DEGs, with upregulated pathways including cocaine addiction and downregulated pathways involving synaptic signaling.
- Highlighted Fos, Crh, Oprl1, and Slc17a6 as key hub genes, validated computationally and experimentally.
- Connectivity mapping suggested D-64131 and Mebendazole as potential therapeutics.
Conclusions:
- METH induces significant transcriptional alterations in the NAc, impacting synaptic function and addiction pathways.
- Integrated in silico and experimental approaches identified robust hub genes.
- Identified candidate compounds for future therapeutic development against METH addiction.
